A Trial of Recaticimab and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable BTC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Trial of Recaticimab and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable BTC	Biliary Tract Carcinoma	Not yet recruiting	Phase 2	2025-07-14		NCT07062328

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Jiangsu Hengrui Pharmaceutical Co., Ltd.	29
Sun Yat-sen University	606

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials